Rotary Melbourne Lunch 2 July
Event description
Rotary Melbourne Weekly Club Meeting - 2 July 2025
Guest Speaker Dr Christos Papadimitriou, Managing Director & CEO Tessara
Topic 'Mini Human Brains, Maximum Impact: Fast‑Tracking Cures for Neurological Diseases'
Details 12.30 for 12.50 - 2.00pm at No35 Sofitel Melbourne & by ZOOM
Venue No35 Sofitel Melbourne
Neurological disorders are now the world’s leading cause of ill-health and disability. Yet, we still lack effective treatments for Alzheimer’s, dementia, and other neurodegenerative diseases.
As the world moves away from animal testing, technologies like Tessara Therapeutics’ RealBrain®—lab-grown human neural tissues—offer a smarter, faster way forward. By mimicking real human biology, they promise more accurate drug testing, quicker discovery, and lower development costs.
This talk explores how human-relevant research can fast-track better, safer treatments to the people who need them most.
Dr. Christos Papadimitriou is a visionary CEO, serial entrepreneur, and award-winning neuroscientist driving advancements in regenerative medicine and pharmaceutical innovation.
As the CEO and Managing Director of Tessara Therapeutics, he spearheaded the development and commercialisation of RealBrain® technology, a groundbreaking human-mimetic 3D brain tissue that transforms drug discovery and therapeutic applications.
A global leader in life sciences, Christos has held key research roles at prestigious institutions, including Johns Hopkins Medical School, ETH Zurich, and the German Center for Neurodegenerative Diseases. With an exceptional ability to blend science with business acumen, Christos has successfully secured significant financial backing through diverse sources, including institutional investors, government initiatives, and private markets, propelling Tessara's emergence as a leading deep-tech company.
His leadership and global collaborations continue to shape the future of healthcare and drug development with ingenuity and purpose.
Join us for an informative lunch on the edge of technology.
Tickets for good, not greed Humanitix dedicates 100% of profits from booking fees to charity